Drug Guide

Generic Name

Acetaminophen, Clemastine Fumarate, Pseudoephedrine Hydrochloride

Brand Names Tavist Allergy/Sinus/Headache

Classification

Therapeutic: Allergy, Cold, and Pain Relief

Pharmacological: Combination of analgesic, antihistamine, and decongestant

FDA Approved Indications

  • Relief of allergy symptoms such as runny nose, sneezing, itchy eyes, and nasal congestion
  • Temporary relief of headache and minor pain associated with cold and allergy symptoms

Mechanism of Action

Acetaminophen: inhibits prostaglandin synthesis in the central nervous system, reducing pain and fever; Clemastine Fumarate: antihistamine that blocks H1 receptors, reducing allergic responses; Pseudoephedrine Hydrochloride: adrenergic agonist that constricts blood vessels in nasal passages, decreasing nasal congestion.

Dosage and Administration

Adult: Follow package instructions; generally, 1-2 tablets every 4-6 hours as needed, not exceeding 8 doses in 24 hours

Pediatric: Consult specific product dosing; generally, not recommended for children under certain ages without physician guidance

Geriatric: Adjust dose based on renal and hepatic function; caution due to increased sensitivity to side effects

Renal Impairment: Use with caution; dose adjustment may be necessary

Hepatic Impairment: Use with caution due to acetaminophen component; monitor liver function

Pharmacokinetics

Absorption: Rapid from gastrointestinal tract

Distribution: Widely distributed, crosses the blood-brain barrier

Metabolism: Acetaminophen: primarily hepatic; Clemastine: hepatic CYP enzymes; Pseudoephedrine: minimal hepatic metabolism

Excretion: Renal, primarily as conjugates of acetaminophen and metabolites

Half Life: Acetaminophen: 2-3 hours; Clemastine: approximately 12-19 hours; Pseudoephedrine: 6-12 hours

Contraindications

  • Hypersensitivity to any component
  • Severe hepatic impairment (acetaminophen)
  • Prostate hypertrophy, urinary retention (pseudoephedrine)

Precautions

  • Use caution in MAOI use, hypertension, cardiovascular disease, glaucoma, and elderly; monitor for anticholinergic effects from clemastine

Adverse Reactions - Common

  • Drowsiness, dizziness (Common)
  • Dry mouth, blurred vision (Common)

Adverse Reactions - Serious

  • Respiratory depression, hepatotoxicity (acetaminophen overdose) (Serious but less common)
  • Serious allergic reactions, tachycardia, hypertension (pseudoephedrine) (Serious but less common)

Drug-Drug Interactions

  • MAOIs (risk of hypertensive crisis with pseudoephedrine)
  • Other CNS depressants (additive drowsiness)

Drug-Food Interactions

N/A

Drug-Herb Interactions

N/A

Nursing Implications

Assessment: Monitor for allergic reactions, drowsiness, blood pressure, and signs of overdose

Diagnoses:

  • Risk for injury due to dizziness or drowsiness
  • Ineffective airway clearance if allergic reactions occur

Implementation: Administer as directed, monitor patient response, advise caution with operating machinery

Evaluation: Assess relief of symptoms, monitor for adverse effects

Patient/Family Teaching

  • Do not exceed recommended dose to avoid hepatotoxicity
  • Caution when operating machinery due to drowsiness
  • Report signs of allergic reactions or unusual side effects
  • Inform about potential increase in blood pressure with pseudoephedrine

Special Considerations

Black Box Warnings:

  • Potential for hepatotoxicity with overdose or chronic use of acetaminophen

Genetic Factors: Metabolism of drugs may vary with genetic polymorphisms

Lab Test Interference: None significant

Overdose Management

Signs/Symptoms: Nausea, vomiting, abdominal pain, hepatotoxicity, CNS depression

Treatment: Immediate assessment, activated charcoal if recent ingestion, acetylcysteine for acetaminophen overdose, symptomatic treatment as needed

Storage and Handling

Storage: Store in a cool, dry place away from light

Stability: Stable within expiration date when stored properly

This guide is for educational purposes only and is not intended for clinical use.